Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 4/20 | 0.65 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.63 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.42 |
| ▸ | KDM5A | P29375 | 3/20 | 0.41 |
| ▸ | PHF8 | Q9UPP1 | 3/20 | 0.41 |
| ▸ | KDM2A | Q9Y2K7 | 3/20 | 0.41 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.41 |
| ▸ | KDM4A | O75164 | 1/20 | 0.39 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | CEL | P19835 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10643742 | 0.96 | SIGMAR1 (0.62) | SIGMAR1CYP1A2EPHX1KDM5APHF8 | |
| SCHEMBL9190697 | 0.96 | SIGMAR1 (0.70) | SIGMAR1CYP1A2EPHX1KDM5APHF8 | |
| SCHEMBL11653901 | 0.96 | SIGMAR1 (0.70) | SIGMAR1CYP1A2EPHX1KDM5APHF8 | |
| SCHEMBL8023611 | 0.96 | SIGMAR1 (0.70) | SIGMAR1CYP1A2EPHX1KDM5APHF8 | |
| SCHEMBL5614191 | 0.96 | SIGMAR1 (0.70) | SIGMAR1CYP1A2EPHX1KDM5APHF8 | |
| SCHEMBL9194529 | 0.93 | SIGMAR1 (0.75) | SIGMAR1CYP1A2EPHX1KDM5APHF8 | |
| SCHEMBL9717338 | 0.93 | SIGMAR1 (0.75) | SIGMAR1CYP1A2EPHX1KDM5APHF8 | |
| SCHEMBL728711 | 0.93 | SIGMAR1 (0.75) | SIGMAR1CYP1A2EPHX1KDM5APHF8 | |
| SCHEMBL7915243 | 0.93 | SIGMAR1 (0.75) | SIGMAR1CYP1A2EPHX1KDM5APHF8 | |
| SCHEMBL4466278 | 0.93 | SIGMAR1 (0.75) | SIGMAR1CYP1A2EPHX1KDM5APHF8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110760192-A | Regenerated seal and preparation method thereof | 江苏路耐德公路养护技术有限公司 | 2020-02-07 | — | — | CN | claimed |
| CN-120005478-A | Asphalt pavement regenerated sealing agent and preparation method thereof | 广东路华沥青工程有限公司 | 2025-05-16 | — | — | CN | disclosed |
| CN-110760192-A | Regenerated seal and preparation method thereof | 江苏路耐德公路养护技术有限公司 | 2020-02-07 | — | — | CN | disclosed |
| CN-110760192-A | Regenerated seal and preparation method thereof | 江苏路耐德公路养护技术有限公司 | 2020-02-07 | — | — | CN | disclosed |
| EP-2590973-B1 | SOLIFENACIN SALTS | CRYSTAL PHARMA SAU (ES) | 2016-08-31 | — | — | EP | disclosed |
| US-8765785-B2 | Solifenacin salts | CRYSTAL PHARMA, S.A.U. (ES) | 2014-07-01 | — | — | US | disclosed |
| US-20130203804-A1 | SOLIFENACIN SALTS | CRYSTAL PHARMA, S.A.U. (ES) | 2013-08-08 | — | — | US | disclosed |
| EP-2590973-A1 | SOLIFENACIN SALTS | Crystal Pharma S.A.U (ES) | 2013-05-15 | — | — | EP | disclosed |
| WO-2012079583-A1 | SYSTEM PROVIDING CONTROLLED DELIVERY OF GASEOUS CO FOR CARBONYLATION REACTIONS | AARHUS UNIVERSITET (DK) | 2012-06-21 | — | — | WO | disclosed |
| WO-2012004264-A1 | SOLIFENACIN SALTS | RAGACTIVES, S.L.U. (ES) | 2012-01-12 | — | — | WO | disclosed |
| WO-2010031408-A2 | GEL COMPOSITIONS | AARHUS UNIVERSITET (DK) | 2010-03-25 | — | — | WO | disclosed |
| EP-1268433-A1 | CYCLIC LACTAMS AS INHIBITORS OF A-BETA-PROTEIN PRODUCTION | Bristol-Myers Squibb Pharma Company (US) | 2003-01-02 | — | — | EP | disclosed |
| WO-2001074783-A1 | CYCLIC LACTAMS AS INHIBITORS OF A ΒΕΤΑ PROTEIN PRODUCTION | DUPONT PHARMACEUTICALS COMPANY (US) | 2001-10-11 | — | — | WO | disclosed |